Warning: The NCBI web site requires JavaScript to function. more...
Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.
Anderson R, Franch A, Castell M, Perez-Cano FJ, Bräuer R, Pohlers D, Gajda M, Siskos AP, Katsila T, Tamvakopoulos C, Rauchhaus U, Panzner S, Kinne RW.
Arthritis Res Ther. 2010;12(4):R147. Epub 2010 Jul 19.
Related citations
Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis.
van den Hoven JM, Hofkens W, Wauben MH, Wagenaar-Hilbers JP, Beijnen JH, Nuijen B, Metselaar JM, Storm G.
Int J Pharm. 2011 Sep 20;416(2):471-7. Epub 2011 Apr 2.
Syntheses of click PEG-dexamethasone conjugates for the treatment of rheumatoid arthritis.
Liu XM, Quan LD, Tian J, Laquer FC, Ciborowski P, Wang D.
Biomacromolecules. 2010 Oct 11;11(10):2621-8.
Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate.
Ishihara T, Kubota T, Choi T, Higaki M.
J Pharmacol Exp Ther. 2009 May;329(2):412-7. Epub 2009 Feb 25.
Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.
Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, Storm G.
Arthritis Rheum. 2003 Jul;48(7):2059-66.
Development of a corticosteroid incorporated in lipid microspheres (liposteroid).
Yokoyama K, Okamoto H, Watanabe M, Suyama T, Mizushima Y.
Drugs Exp Clin Res. 1985;11(9):611-20.
Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis.
Koning GA, Schiffelers RM, Wauben MH, Kok RJ, Mastrobattista E, Molema G, ten Hagen TL, Storm G.
Arthritis Rheum. 2006 Apr;54(4):1198-208.
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis.
Corvo ML, Boerman OC, Oyen WJ, Van Bloois L, Cruz ME, Crommelin DJ, Storm G.
Biochim Biophys Acta. 1999 Jul 15;1419(2):325-34.
Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis.
Williams AS, Camilleri JP, Amos N, Williams BD.
Clin Exp Immunol. 1995 Dec;102(3):560-5.
Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate.
Higaki M, Ishihara T, Izumo N, Takatsu M, Mizushima Y.
Ann Rheum Dis. 2005 Aug;64(8):1132-6. Epub 2005 Feb 4.
Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis.
Avnir Y, Ulmansky R, Wasserman V, Even-Chen S, Broyer M, Barenholz Y, Naparstek Y.
Arthritis Rheum. 2008 Jan;58(1):119-29.
Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes.
Kinne RW, Schmidt-Weber CB, Hoppe R, Buchner E, Palombo-Kinne E, Nürnberg E, Emmrich F.
Arthritis Rheum. 1995 Dec;38(12):1777-90.
Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.
Williams AS, Jones SG, Goodfellow RM, Amos N, Williams BD.
Br J Pharmacol. 1999 Sep;128(1):234-40.
Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis.
Luisa Corvo M, Jorge JC, van't Hof R, Cruz ME, Crommelin DJ, Storm G.
Biochim Biophys Acta. 2002 Aug 19;1564(1):227-36.
Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats.
Bendele AM, McComb J, Gould T, Frazier J, Chlipala ES, Seely J, Kieft G, Wolf J, Edwards CK 3rd.
Inflamm Res. 1999 Aug;48(8):453-60.
Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment.
Rauchhaus U, Schwaiger FW, Panzner S.
Arthritis Res Ther. 2009;11(6):R190. Epub 2009 Dec 15.
The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations.
Williams A, Goodfellow R, Topley N, Amos N, Williams B.
Inflamm Res. 2000 Apr;49(4):155-61.
Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis.
Gaspar MM, Boerman OC, Laverman P, Corvo ML, Storm G, Cruz ME.
J Control Release. 2007 Feb 12;117(2):186-95. Epub 2006 Nov 10.
Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis.
Metselaar JM, van den Berg WB, Holthuysen AE, Wauben MH, Storm G, van Lent PL.
Ann Rheum Dis. 2004 Apr;63(4):348-53.
Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agents.
Ishihara T, Takahashi M, Higaki M, Mizushima Y, Mizushima T.
Int J Pharm. 2010 Jan 29;385(1-2):170-5. Epub 2009 Oct 28.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on